Beta Development Updates. Beta will keep Xeris reasonably informed on the status, progress, and results of all Beta Development Activities and other Development of the Glucagon Product conducted pursuant to this Agreement by providing the JSC with a report containing summaries of the Development Results each Calendar Quarter in the format specified in the Development Plan or other format to be agreed by the Parties. In the event of any termination of this Agreement during the Development Term after Beta has commenced the Beta Development Activities, Beta will promptly provide to Xeris a final report of all data and other results generated pursuant to the Beta Development Activities and other Development of the Glucagon Product conducted pursuant to this Agreement.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Beta Bionics, Inc), Collaboration and License Agreement (Beta Bionics, Inc)